These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12368036)

  • 1. Use of an adenoviral vector to express soluble donor-major histocompatibility complex molecules capable of suppressing the immune response in rat transplant recipients.
    Graeb C; Justl M; Scherer MN; Andrassy J; Frank E; Zuelke C; Jauch KW; Geissler EK
    Hum Immunol; 2002 Oct; 63(10):844-52. PubMed ID: 12368036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte expression of soluble donor MHC class I antigen via gene transfer inhibits multiple aspects of the antidonor immune response in fully sensitized rat transplant recipients.
    Graeb C; Scherer MN; Kroemer A; Jauch KW; Geissler EK
    Hum Immunol; 2002 Oct; 63(10):948-54. PubMed ID: 12368047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-derived soluble MHC antigens plus low-dose cyclosporine induce transplantation unresponsiveness independent of the thymus by down-regulating T cell-mediated alloresponses in a rat transplantation model.
    Behrens D; Lange K; Fried A; Yoo-Ott KA; Richter K; Fändrich F; Krönke M; Zavazava N
    Transplantation; 2001 Dec; 72(12):1974-82. PubMed ID: 11773898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules.
    Graeb C; Scherer MN; Knechtle SJ; Geissler EK
    Hum Immunol; 1998 Jul; 59(7):415-25. PubMed ID: 9684991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model.
    Hanaway MJ; Geissler EK; Wang J; Fechner JH; Buelow R; Knechtle SJ
    Transplantation; 1996 Apr; 61(8):1222-8. PubMed ID: 8610422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipients.
    Geissler EK; Graeb C; Tange S; Guba M; Jauch KW; Scherer MN
    Hum Gene Ther; 2000 Feb; 11(3):459-69. PubMed ID: 10697120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high-responder heart transplant model.
    Geissler EK; Scherer MN; Graeb C
    Transpl Int; 2000; 13 Suppl 1():S452-5. PubMed ID: 11112052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1992 Oct; 216(4):409-14; discussion 414-6. PubMed ID: 1417190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of high levels of soluble allogeneic major histocompatability complex class I antigen by adenoviral gene transfer strongly inhibits allospecific cytotoxic T lymphocytes in vivo.
    Graeb C; Justl M; Scherer MN; Tange S; Frank E; Jauch KW; Geissler EK
    Transplant Proc; 2002 Aug; 34(5):1398-9. PubMed ID: 12176413
    [No Abstract]   [Full Text] [Related]  

  • 14. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
    Yu S; Nakafusa Y; Flye MW
    Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.
    Inoue S; Popp FC; Koehl GE; Piso P; Schlitt HJ; Geissler EK; Dahlke MH
    Transplantation; 2006 Jun; 81(11):1589-95. PubMed ID: 16770249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies.
    Yamashita K; Masunaga T; Yanagida N; Takehara M; Hashimoto T; Kobayashi T; Echizenya H; Hua N; Fujita M; Murakami M; Furukawa H; Uede T; Todo S
    Transplantation; 2003 Oct; 76(7):1089-96. PubMed ID: 14557758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection.
    Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC
    Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival.
    Oluwole SF; Lau HT; Reemtsma K; Hardy MA
    Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells.
    Garrovillo M; Ali A; Oluwole SF
    Transplantation; 1999 Dec; 68(12):1827-34. PubMed ID: 10628758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.